Whether Humacyte ultimately succeeds depends on its ability to successfully scale commercial sales of its bioengineered products, secure broad regulatory clearances across international markets, and manage operational cash flows efficiently. While its scientific breakthroughs in regenerative medicine provide a strong foundation, long-term survival requires consistent clinical validation, widespread hospital adoption, and successful navigation of competitive medical device markets.